Smita Bhatia Selected Research

Second Primary Neoplasms (Neoplasms, Second)

1/2022	Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.
1/2018	Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
8/2015	Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.
7/2011	Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.
5/2009	Late morbidity after successful treatment of children with cancer.
10/2007	Second malignancies after allogeneic hematopoietic cell transplantation.
12/2003	High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.
6/2002	Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Smita Bhatia Research Topics

Disease

118	Neoplasms (Cancer) 10/2022 - 02/2002
24	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 06/2002
22	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2008
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 03/2003
14	Lymphoma (Lymphomas) 03/2022 - 03/2003
13	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 06/2005
13	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 09/2005
13	Heart Failure 11/2020 - 06/2008
13	Leukemia 12/2018 - 04/2002
10	Hypertension (High Blood Pressure) 03/2022 - 02/2007
9	Cardiomyopathies (Cardiomyopathy) 01/2022 - 05/2012
8	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 06/2002
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 09/2005
7	Multiple Myeloma 01/2022 - 10/2008
7	Frailty 01/2022 - 10/2016
6	Infections 01/2022 - 01/2005
6	Bronchiolitis Obliterans Syndrome 01/2021 - 10/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 08/2008
6	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2017 - 07/2008
5	Hearing Loss (Hearing Impairment) 11/2021 - 12/2012
5	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 01/2007
5	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 12/2013
5	Genetic Predisposition to Disease (Genetic Predisposition) 11/2017 - 07/2002
4	Cognitive Dysfunction 01/2022 - 10/2018
4	Stroke (Strokes) 01/2022 - 04/2016
4	Chronic Disease (Chronic Diseases) 12/2020 - 02/2005
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 09/2004
3	Venous Thromboembolism 10/2022 - 11/2019
3	Dyslipidemias (Dyslipidemia) 03/2022 - 11/2012
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 05/2018
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 11/2018
3	Death (Near-Death Experience) 01/2022 - 09/2012
3	Pain (Aches) 11/2021 - 01/2020
3	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 02/2014
3	Colorectal Neoplasms (Colorectal Cancer) 05/2019 - 01/2018
3	Neuroblastoma 05/2018 - 01/2011
2	Cataract (Cataracts) 10/2022 - 01/2018
2	Obesity 03/2022 - 01/2019
2	Genetic Risk Score 01/2022 - 03/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 04/2016
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2022 - 01/2019
2	Sickle Cell Anemia (Hemoglobin S Disease) 12/2021 - 01/2020
2	Ototoxicity 11/2021 - 02/2014
2	Fatigue 11/2021 - 08/2015
2	Carcinogenesis 01/2021 - 12/2012
2	Necrosis 01/2020 - 09/2009
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2019 - 12/2012
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 10/2008
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 12/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2017 - 03/2003
2	Wilms Tumor (Wilm's Tumor) 03/2016 - 07/2012
2	Left Ventricular Dysfunction 12/2014 - 05/2014
1	Rhabdomyosarcoma 03/2022
1	Prehypertension 03/2022

Drug/Important Bio-Agent (IBA)

20	AnthracyclinesIBA 10/2021 - 06/2008
10	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2022 - 06/2012
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2012
6	Alkylating AgentsIBA 12/2020 - 03/2016
5	Dihydrotachysterol (AT 10)IBA 01/2020 - 06/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 10/2013
4	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022 - 11/2019
3	Thioguanine (Tioguanine)FDA Link 01/2021 - 06/2015
3	NucleotidesIBA 01/2021 - 06/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 11/2019
3	insulin receptor-related receptor (IRR)IBA 01/2020 - 04/2016
3	Estrogen ReceptorsIBA 01/2019 - 09/2009
2	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2022 - 08/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 04/2017
2	Trastuzumab (Herceptin)FDA Link 11/2020 - 09/2009
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 02/2014
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 08/2008
2	Tyrosine Kinase InhibitorsIBA 11/2019 - 01/2019
2	Busulfan (Busulfex)FDA Link 11/2019 - 01/2019
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 10/2008
2	Lenalidomide (CC 5013)FDA Link 01/2018 - 02/2013
2	human ERBB2 proteinIBA 01/2015 - 11/2008
2	Alcohol OxidoreductasesIBA 05/2012 - 06/2008
2	Biological ProductsIBA 01/2011 - 12/2005
2	Tacrolimus (Prograf)FDA LinkGeneric 09/2009 - 10/2008

Therapy/Procedure

87	Therapeutics 06/2022 - 02/2002
32	Cell Transplantation 01/2021 - 09/2004
25	Transplantation 10/2022 - 03/2003
23	Radiotherapy 01/2022 - 07/2008
22	Drug Therapy (Chemotherapy) 03/2022 - 07/2008
7	Terminal Care (Care, Terminal) 01/2020 - 01/2017
7	Aftercare (After-Treatment) 05/2019 - 12/2004
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 02/2007
5	Autologous Transplantation 01/2022 - 03/2003
4	Activities of Daily Living (ADL) 01/2022 - 12/2020
3	Palliative Care (Palliative Therapy) 01/2022 - 09/2012
3	Ambulatory Care (Outpatient Care) 01/2022 - 12/2012
3	Hematopoietic Stem Cell Transplantation 01/2017 - 02/2009
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2022 - 10/2021
2	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 07/2008
2	Stem Cell Transplantation 05/2017 - 02/2013
1	Replacement Arthroplasty 10/2022
1	Salvage Therapy 10/2022